GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Cyclically Adjusted FCF per Share

Imexpharm (STC:IMP) Cyclically Adjusted FCF per Share : ₫-127.41 (As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Imexpharm Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Imexpharm's adjusted free cash flow per share for the three months ended in Mar. 2025 was ₫-1,005.505. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₫-127.41 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 32.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Imexpharm was 32.00% per year. The lowest was 32.00% per year. And the median was 32.00% per year.

As of today (2025-06-23), Imexpharm's current stock price is ₫51100.00. Imexpharm's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₫-127.41. Imexpharm's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Imexpharm was 2405.00. The lowest was 202.59. And the median was 1780.08.


Imexpharm Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Imexpharm's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imexpharm Cyclically Adjusted FCF per Share Chart

Imexpharm Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -110.24 65.01 -119.79 -34.73

Imexpharm Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -87.36 -102.26 -68.09 -34.73 -127.41

Competitive Comparison of Imexpharm's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Imexpharm's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imexpharm's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Imexpharm's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Imexpharm's Cyclically Adjusted Price-to-FCF falls into.


;
;

Imexpharm Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Imexpharm's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-1005.505/134.9266*134.9266
=-1,005.505

Current CPI (Mar. 2025) = 134.9266.

Imexpharm Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 27.301 100.684 36.586
201509 -164.767 100.392 -221.448
201512 599.822 99.792 811.003
201603 -254.500 100.470 -341.780
201606 374.575 101.688 497.011
201609 -649.407 101.861 -860.214
201612 261.637 101.863 346.562
201703 -1,001.661 102.862 -1,313.901
201706 -316.030 103.349 -412.590
201709 -98.987 104.136 -128.256
201712 28.666 104.011 37.186
201803 -1,280.945 105.290 -1,641.508
201806 -340.664 106.317 -432.337
201809 64.278 106.507 81.430
201812 505.279 105.998 643.179
201903 -869.748 107.251 -1,094.187
201906 19.572 108.070 24.436
201909 97.766 108.329 121.770
201912 335.078 108.420 416.998
202003 -157.630 108.902 -195.300
202006 55.511 108.767 68.862
202009 -500.511 109.815 -614.964
202012 589.149 109.897 723.332
202103 187.468 111.754 226.339
202106 223.901 114.631 263.542
202109 71.825 115.734 83.736
202112 658.282 117.630 755.081
202203 459.541 121.301 511.161
202206 471.249 125.017 508.604
202209 221.219 125.227 238.355
202212 538.634 125.222 580.379
202303 -326.349 127.348 -345.771
202306 -387.014 128.729 -405.648
202309 -433.577 129.860 -450.495
202312 502.934 129.419 524.335
202403 -220.382 131.776 -225.651
202406 216.530 132.554 220.406
202409 419.030 133.029 425.008
202412 266.634 133.157 270.177
202503 -1,005.505 134.927 -1,005.505

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Imexpharm  (STC:IMP) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Imexpharm was 2405.00. The lowest was 202.59. And the median was 1780.08.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Imexpharm Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Imexpharm's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Imexpharm Business Description

Industry
Traded in Other Exchanges
N/A
Address
4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. Its products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.

Imexpharm Headlines

No Headlines